THE INFLUENCE OF THE PREBIOTIC «ZACOFALK NMX®» ON MOLECULAR PATHWAYS IN CELIAC DISEASE
- Authors: Sarvilina I.1
-
Affiliations:
- Medical Centre «Novomeditsina»
- Issue: Vol 25, No 10 (2014)
- Pages: 26-31
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116143
- ID: 116143
Cite item
Open Access
Access granted
Abstract
This study is aimed at researching the influence of the Zacofalk NMX® on molecular pathways in coeliac disease.
Keywords
Full Text
About the authors
I. Sarvilina
Medical Centre «Novomeditsina»
Email: isarvilina@mail.ru
MD Rostov-on-Don, Russia
References
- Корниенко Е.А. Нарушение толерантности к глютену как пусковой фактор в развитии целиакии // Педиатрия. - 2013; 6: 126-34.
- Abdulkarim A., Murray J. Review article: the diagnosis of coeliac disease // Aliment. Pharmacol. Ther. - 2003; 17: 987-95.
- Catassi C., Fanciulli G., D'Appello A. et al. Antiendomysium versus antigliadin antibodies in screening the general population for coeliac disease // Scand. J. Gastroenterol. - 2000; 35: 732-6.
- Fasano A. European and North American populations should be screened for coeliac disease // Gut. - 2003; 52: 168-9.
- Fasano A., Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum // Gastroenterology. - 2001; 120: 636-51.
- Fasano A., Berti I, Gerarduzzi T. et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study // Arch. Intern. Med. - 2003; 163: 286-92.
- Logan R. Problems and pitfalls in epidemiological studies of coeliac disease. In: Auricchio S., Visakorpi J. eds. Common food intolerances 1: Epidemiology of coeliac disease / Basel: Karger, 1992; p 14-24.
- Monsuur A., de Bakker P., Zhernakova A. et al. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms // PLoS One. - 2008; 3 (5): e2270.
Supplementary files
